Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2013, Article ID 717480, 5 pages
http://dx.doi.org/10.1155/2013/717480
Clinical Study

Thrombophilic Genetic Factors PAI-1, MTHFRC677T, V Leiden 506Q, and Prothrombin 20210A in Noncirrhotic Portal Vein Thrombosis and Budd-Chiari Syndrome in a Caucasian Population

1Department of Biopathology and Medical and Forensic Biotechnologies and Biomedical Department of Internal and Specialist Medicine, University of Palermo, Palermo, Italy
2Department of Oncology and Hematology, Cervello Hospital, Via Trabucco 180, 90146 Palermo, Italy
3Department of Medicine, Cervello Hospital, Via Trabucco 180, 90146 Palermo, Italy

Received 15 July 2013; Revised 15 September 2013; Accepted 30 September 2013

Academic Editor: Raphael Guzman

Copyright © 2013 Mario D’Amico et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Pasta, C. Marrone, M. D'Amico et al., “MTHFR C677T mutations in liver cirrhosis with and without portal vein thrombosis,” Liver International, vol. 26, no. 2, pp. 269–270, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. M. D'Amico, L. Pasta, and P. Sammarco, “MTHFR C677TT, PAI1 4G-4G, V Leiden Q506, and prothrombin G20210A in hepatocellular carcinoma with and without portal vein thrombosis,” Journal of Thrombosis and Thrombolysis, vol. 28, no. 1, pp. 70–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Parikh, R. Shah, and P. Kapoor, “Portal vein thrombosis,” The American Journal of Medicine, vol. 123, no. 2, pp. 111–119, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Primignani and P. M. Mannucci, “The role of thrombophilia in splanchnic vein thrombosis,” Seminars in Liver Disease, vol. 28, no. 3, pp. 293–301, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. E. S. Jaffe, N. L. Harris, H. Stein, and J. W. Vardiman, Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues, World Health Organization Classification of Tumors, IARC Press, Lyon, France, 2001.
  6. S. Rodriguez, T. R. Gaunt, and I. N. Day, “Hardy-Weinberg equilibrium testing of biological ascertainment for mendelian randomization studies,” The American Journal of Epidemiology, vol. 169, no. 4, pp. 505–514, 2008. View at Publisher · View at Google Scholar
  7. “2-way Contingency Table Analysis,” 2011, http://statpages.org/ctab2x2.html.
  8. G. Balta, C. Altay, and A. Gurgey, “PAI-1 gene 4G/5G genotype: a risk factor for thrombosis in vessels of internal organs,” The American Journal of Hematology, vol. 71, no. 2, pp. 89–93, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. A. E. Tsantes, G. K. Nikolopoulos, P. G. Bagos, S. Bonovas, P. Kopterides, and G. Vaiopoulos, “The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk,” Thrombosis Research, vol. 122, no. 6, pp. 736–742, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Palmirotta, P. Ferroni, A. Savonarola et al., “Prognostic value of pre-surgical plasma PAI-1 (plasminogen activator inhibitor-1) levels in breast cancer,” Thrombosis Research, vol. 124, no. 4, pp. 403–408, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Mostowska, M. Myka, M. Lianeri, A. Roszak, and P. P. Jagodziński, “Folate and choline metabolism gene variants and development of uterine cervical carcinoma,” Clinical Biochemistry, vol. 44, no. 8-9, pp. 596–600, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Zoodsma, I. M. Nolte, M. Schipper et al., “Methylenetetrahydrofolate reductase (MTHFR) and susceptibility for (pre)neoplastic cervical disease,” Human Genetics, vol. 116, no. 4, pp. 247–254, 2005. View at Publisher · View at Google Scholar
  13. A. F. Lambropoulos, T. Agorastos, Z. J. Foka et al., “Methylenetetrahydrofolate reductase polymorphism C677T is not associated to the risk of cervical dysplasia,” Cancer Letters, vol. 191, no. 2, pp. 187–191, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. H. L. A. Janssen, J. R. Meinardi, F. P. Vleggaar et al., “Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study,” Blood, vol. 96, no. 7, pp. 2364–2368, 2000. View at Google Scholar · View at Scopus
  15. M. Bhattacharyya, G. Makharia, M. Kannan, R. P. H. Ahmed, P. K. Gupta, and R. Saxena, “Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India,” The American Journal of Clinical Pathology, vol. 121, no. 6, pp. 844–847, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Primignani, I. Martinelli, P. Bucciarelli et al., “Risk factors for thrombophilia in extrahepatic portal vein obstruction,” Hepatology, vol. 41, no. 3, pp. 603–608, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. K. Dutta, A. Chacko, B. George, J. A. Joseph, S. C. Nair, and V. Mathews, “Risk factors of thrombosis in abdominal veins,” World Journal of Gastroenterology, vol. 14, no. 28, pp. 4518–4522, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. D. Murad, A. Plessier, M. Hernandez-Guerra et al., “Etiology, management, and outcome of the Budd-Chiari syndrome,” Annals of Internal Medicine, vol. 151, no. 3, pp. 167–175, 2009. View at Google Scholar
  19. P. L. Bittencourt, C. A. Couto, and D. D. Ribeiro, “Portal vein thrombosis and Budd-Chiari syndrome,” Clinics in Liver Disease, vol. 13, no. 1, pp. 127–144, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Bosch, J. G. Abraldes, M. Fernández, and J. C. García-Pagán, “Hepatic endothelial dysfunction and abnormal angiogenesis: new targets in the treatment of portal hypertension,” Journal of Hepatology, vol. 53, no. 3, pp. 558–567, 2010. View at Publisher · View at Google Scholar